The Alvin and Lois Lapidus Cancer Institute
1 clinical trials · Sponsor
◉ Watch The Alvin and Lois Lapidus Cancer Institute
| Record | Firm | Date |
|---|---|---|
| A Dose Study of Doxil in a Dose Dense, 14 Day CDOP/Rituximab Regimen for Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma (NHL)> 60 Years or With Compromised Cardiac Status. (NCT00333008) | The Alvin and Lois Lapidus Cancer Institute | 2006-05-01 |
Track The Alvin and Lois Lapidus Cancer Institute automatically
Every clearance here is in the API, with alerts when new ones post.